Five years of tamoxifen--or more?
- PMID: 8961965
- DOI: 10.1093/jnci/88.24.1791
Five years of tamoxifen--or more?
Comment on
-
Recent trends in U.S. breast cancer incidence, survival, and mortality rates.J Natl Cancer Inst. 1996 Nov 6;88(21):1571-9. doi: 10.1093/jnci/88.21.1571. J Natl Cancer Inst. 1996. PMID: 8901855
-
Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.J Natl Cancer Inst. 1996 Dec 18;88(24):1828-33. doi: 10.1093/jnci/88.24.1828. J Natl Cancer Inst. 1996. PMID: 8961972 Clinical Trial.
-
Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group.J Natl Cancer Inst. 1996 Dec 18;88(24):1834-9. doi: 10.1093/jnci/88.24.1834. J Natl Cancer Inst. 1996. PMID: 8961973 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical